======= COMMD3-BMI1 ======= == Gene Information == * **Official Symbol**: N/A * **Official Name**: N/A * **Aliases and Previous Symbols**: N/A * **Entrez ID**: N/A * **UniProt**: N/A * **Interactions**: [[https://thebiogrid.org/search.php?search=COMMD3-BMI1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20COMMD3-BMI1|Open PubMed]] * **OMIM**: N/A == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of a Polycomb group (PcG) multiprotein PRC1- like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility (PubMed:15386022, PubMed:16359901, PubMed:26151332, PubMed:16714294, PubMed:21772249, PubMed:25355358, PubMed:27827373). The complex composed of RNF2, UB2D3 and BMI1 binds nucleosomes, and has activity only with nucleosomal histone H2A (PubMed:21772249, PubMed:25355358). In the PRC1-like complex, regulates the E3 ubiquitin-protein ligase activity of RNF2/RING2 (PubMed:15386022, PubMed:26151332, PubMed:21772249). {ECO:0000269|PubMed:15386022, ECO:0000269|PubMed:16359901, ECO:0000269|PubMed:16714294, ECO:0000269|PubMed:16882984, ECO:0000269|PubMed:21772249, ECO:0000269|PubMed:25355358, ECO:0000269|PubMed:26151332, ECO:0000269|PubMed:27827373}. |zf-C3HC4| |HCaRG| |histone H2A-K119 monoubiquitination| |PRC1 complex| |histone H2A monoubiquitination| |histone H2A ubiquitination| |histone monoubiquitination| |histone ubiquitination| |promoter-specific chromatin binding| |chromatin organization involved in negative regulation of transcription| |chromatin silencing| |protein monoubiquitination| |chromatin organization involved in regulation of transcription| |negative regulation of gene expression, epigenetic| |gene silencing| |regulation of gene expression, epigenetic| |histone modification| |covalent chromatin modification| |protein ubiquitination| |chromatin organization| |protein modification by small protein conjugation| |negative regulation of transcription by RNA polymerase II| |protein modification by small protein conjugation or removal| |chromosome organization| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |negative regulation of gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.16| |[[:results:exp432|YM155 0.001μM R08 exp432]]|-2.02| |[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-1.74| |[[:results:exp470|Chloroquine 32μM R08 exp470]]|-1.71| |[[:results:exp153|SGC2096 2.6μM R03 exp153]]|1.73| |[[:results:exp264|Arsenate 40μM R06 exp264]]|1.9| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: N/A ^Tissue^Fraction Of Cell Lines Where Essential^ == Essentiality in NALM6 == * **Essentiality Rank**: 7479 * **Expression level (log2 read counts)**: 4.12 {{:chemogenomics:nalm6 dist.png?nolink |}}